AI is increasingly proliferating the healthcare landscape and has immense promise for improving health outcomes in resource-constrained settings. AI-powered health data analytics can enhance medical diagnostics and improve decision-making when it comes to treatment options and health interventions. With over 1.3 billion people owning a smartphone, AI-based solutions can bring diagnostics to people with limited or no access to medical care, free up capacities of health professionals to focus on critical cases, or help save lives in emergencies by allowing patients to be diagnosed even before they arrive in hospitals for treatment. The COVID-19 pandemic has exacerbated the deployment of AI in healthcare. Making AI tools available to effectively overcome a fast-moving pandemic requires government officials, developers, and health organizations to observe the fundamentals of regulation and focus on use cases and models with reliable and validated datasets. This poses several challenges, such as access to good quality and accurate data, data protection, sharing and privacy, identity, and gender, racial and poverty-based bias.
The panel will discuss:
- How do we build and maintain trustworthy/ethical AI and not stifle healthcare innovation by overregulating?
- How do governments worldwide use innovative and agile regulation to deploy AI and big data solutions amidst the COVID-19 pandemic (sandboxes, public policy labs, fast track programs) ?
Senior Policy Analyst, OECD
Alan Paic is Senior Policy Analyst in the Science and Technology Policy (STP) Division, within the Directorate for Science, Technology and Innovation (DSTI) of the Organisation for Economic Co-operation and Development (OECD). Dr. Paic is in charge of various aspects of science and innovation policy, notably open access to data for science, technology and innovation, Innovation Policy Reviews for non-member countries, and international cooperation in research and innovation for sustainable development.
Chief of the Neuroethics Studies Program, Georgetown University Medical Center
James Giordano is a Chief Scientific Officer at Georgetown University, Samueli-Rockefeller Professor in the Departments of Medicine and Neurosciences, and Scholar in Residence within the Center for Clinical Bioethics at Georgetown University Medical Center.
Lead Counsel, Innovation & Technology, World Bank
David Satola is Lead Counsel, Innovation & Technology, in the Legal Department at the World Bank. He has global responsibility for legal aspects of reforms in information and communications technologies, including telecommunications, the Internet, e-commerce, cybersecurity, data protection and open source software. He leads the World Bank’s initiative to build capacity to combat cybercrime (www.combattingcybercrime.org) and represents the Bank at GFCE’s Working Group C on Cybercrime. He also leads the Bank’s Observer delegation to the Government Advisory Committee (GAC) at ICANN. Prior to joining the Bank, David worked in human rights law in Geneva, and later was involved in communications investments in the United States, Europe, Latin America and Asia, both as in-house legal counsel and in private law practice based in Brussels, London and Atlanta. David received his BA (1982) and MA (1984) in History from Johns Hopkins University. He also received a JD (1986) from the University of Wisconsin and studied at the London School of Economics and the Hague Academy of International Law.
Attorney Advisor, U.S. Patent and Trademark Office
Bratislav Stankovic is an Attorney Advisor with the Office of International Policy at the US Patent and Trademark Office. Dr. Stankovic has over 30 years of experience as a scientist, including 5 years as a Chief Scientist at the NASA-funded Wisconsin Center for Space Automation and Robotics, University of Wisconsin-Madison, where he was the principal investigator for experiments on the Space Shuttle and the International Space Station.
Professor of the Philosophy of Law, LUMSA University
Laura Palazzani is Professor of the Philosophy of Law at the LUMSA University in Rome. A member of the Italian National Bioethics Committee since 2002, from 2008 she has held the position of vice president. She is also part of the International Bioethics Committee of UNESCO (2016) and represents the Italian Government at the Bioethics Committee of the Council of Europe.